Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11690839
Treatment of idiopathic pulmonary fibrosis
granted -
US 11690836
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 11690826
Methods for treating demodex blepharitis using lotilaner formulations
granted -
US 11690829
Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
granted -
US 11690828
Treatment of CNS diseases with sGC stimulators
granted -
US 11692032
Anti-LAG3 antibodies and uses thereof
granted -
US 11691972
Compounds for targeted degradation of BRD9
granted -
US 11690894
Transgenic corn with antifungal peptide AGM182 (DN:0113.18)
granted -
US 11690853
Non-hormonal steroid modulators of NF-κβ for treatment of disease
granted -
US 11690837
Methods of improving cell-based therapy
granted -
US 11690825
20-HETE receptor (GPR75) antagonists and methods of use
granted -
US 11691992
Oxaborole analogs and uses thereof
granted -
US 2023203129
ANTI-HER2 POLYPEPTIDES DERIVATIVES AS NEW DIAGNOSTIC MOLECULAR PROBES
granted -
WO 2023118563
THÉRAPIE POUR MODULER UNE RÉPONSE IMMUNITAIRE AU MOYEN D'UN MVA RECOMBINANT CODANT POUR IL-12
granted -
WO 2023118508
VIRUS MVA RECOMBINANTS POUR ADMINISTRATION INTRAPÉRITONÉALE POUR LE TRAITEMENT DU CANCER
granted -
US 11685775
Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody
granted -
US 11684597
Administration of tailored feedstock to increase nitro-containing amphenicol antibiotic susceptibility
granted -
US 11685780
Single domain antigen binding domains that bind human Trop2
granted -
US 11685744
CDK inhibitors and their use as pharmaceuticals
granted -
US 11684596
Antidiabetic pharmaceutical compositions and preparation method thereof
granted -
US 11684050
Non-human animals having a humanized programmed cell death 1 gene
granted -
US 11686735
Systems and methods to identify and treat subjects at risk for obstetrical complications
granted -
US 11685784
Anti-immune-checkpoint nanobody and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 11685750
Crystalline forms of IRAK degraders
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.